Clinical Trials Browser

Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, Neoplasms

Diffuse Intrinsic Pontine Glioma, Ependymoma, Medulloblastoma, Recurrence

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Mouth Neoplasms, Neoplasms, Squamous Cell

Melanoma, Skin Neoplasms

Solid Tumors

Brain Neoplasms, Glioma

Kidney Neoplasms

Fibrolamellar hepatocellular carcinoma, Carcinoma, Liver Neoplasms

Lung Diseases, Interstitial

Carcinoma, Renal Cell, von Hippel-Lindau Disease

Turcot syndrome, Colorectal Neoplasms

Neoplasm Metastasis

Adenocarcinoma Of Esophagus, Stomach Neoplasms

Advanced Biliary Tract Cancer(BTC)

Carcinoma, Non-Small-Cell Lung

Advanced Kidney Cancer

Carcinoma, Renal Cell

Carcinoma, Hepatocellular

Carcinoma, Hepatocellular

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Carcinoma, Renal Cell

Disease, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

Lung Neoplasms

Carcinoma, Non-Small-Cell Lung

Locally Advanced Rectal Carcinoma

Post-Acute COVID-19 Syndrome, Carcinoma, Non-Small-Cell Lung

Clinical Trials

Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma

PRiME II

Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)

A Study To Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Untreated, Unresectable or Metastatic Melanoma Participants In India

A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With Recurrent Soft Tissue Sarcomas

A Study to Test How Well Different Doses of BI 1831169 in Combination With an Anti-PD1 Antibody Are Tolerated in Japanese People With Different Advanced Cancers

Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)

A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK)

A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)

Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung Disease

MK-6482-043

TORCH-OPTIMA

5-Azacitidine Plus PD-1/PD-L1 Inhibitor With PD-1/PD-L1 Refractory Tumors

A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

NOBLE

FLINN

The Impact of Time-of-day-Dependent Administration of Nivolumab-Ipilimumab (ICI/ICI) Combination on Overall Survival in Adults With Advanced Kidney Cancer: A Pragmatic Multicenter, Randomized Controlled Trial.

IVE in mRCC

Ipilimumab and Nivolumab With SBRT in Locally Advanced Hepatocellular Cancer

GDFATHERHCC01

Decitabine and Nivolumab in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

Modulation of the Bone Immune Microenvironment Following Cabozantinib Treatment of Bone Metastatic Clear Cell Renal Cell Carcinoma: Proof of Concept Study

Golcadomide and Nivolumab in Patients With Non-Hodgkin Lymphoma With Refractory Disease After Chimeric Antigen T-cell Therapy

SPRING

Perioperative Immunotherapy for NSCLC (ECTOP-1030)

Olanzapine Impact on First-line Immunotherapy for Advanced EGFR-negative NSCLC

PREDICT

LUNGVIR